Authors:
ALTMAN LC
MUNK Z
SELTZER J
NOONAN N
SHINGO S
ZHANG J
REISS TF
Citation: Lc. Altman et al., A PLACEBO-CONTROLLED, DOSE-RANGING STUDY OF MONTELUKAST, A CYSTEINYL LEUKOTRIENE-RECEPTOR ANTAGONIST, Journal of allergy and clinical immunology, 102(1), 1998, pp. 50-56
Authors:
REISS TF
CHERVINSKY P
DOCKHORN RJ
SHINGO S
SEIDENBERG B
EDWARDS TB
Citation: Tf. Reiss et al., MONTELUKAST, A ONCE-DAILY LEUKOTRIENE RECEPTOR ANTAGONIST, IN THE TREATMENT OF CHRONIC ASTHMA - A MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL, Archives of internal medicine, 158(11), 1998, pp. 1213-1220
Authors:
ZHANG J
CHERVINSKY P
EDWARDS T
DOCKHORN R
NAYAK A
NOONAN G
HESS J
SHINGO S
REISS TF
Citation: J. Zhang et al., MONTELUKAST, A CYS LT(1) RECEPTOR ANTAGONIST, DECREASES PERIPHERAL-BLOOD EOSINOPHILS AND IMPROVES SIGNS AND SYMPTOMS OF ASTHMA OVER A 3 MONTH PERIOD, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1095-1095
Authors:
ISHII H
SHINGO S
HARADA S
HIRANO S
IWATA Y
HARA T
YOSHIDA N
FUJINO K
SATO K
Citation: H. Ishii et al., INTERGRANULAR TRANSPORT-PROPERTIES IN C-AXIS ORIENTED YBA2CU3OY POLYCRYSTALLINE FILMS, Applied physics letters, 71(16), 1997, pp. 2367-2369
Authors:
HILLINGSO J
KJELDSEN J
LAURITSEN K
VONSPRECKELSEN S
DEPRE M
FRIEDMAN BS
MALMSTROM K
SHINGO S
BUKHAVE K
RASKMADSEN J
Citation: J. Hillingso et al., BLOCKADE OF LEUKOTRIENE PRODUCTION BY A SINGLE ORAL DOSE OF MK-0591 IN ACTIVE ULCERATIVE-COLITIS, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 335-341
Authors:
HILLINGSO J
KJELDSEN J
LAURSEN LS
LAURITSEN K
VONSPRECKELSEN S
DEPRE M
FRIEDMAN BS
MALMSTROM K
SHINGO S
BUKHAVE K
RASKMADSEN J
Citation: J. Hillingso et al., SELECTIVE BLOCKADE OF RECTAL LEUKOTRIENE-B4 (LTB4) AND SYSTEMIC LEUKOTRIENE PRODUCTION BY A SINGLE, ORAL DOSE OF MK-591 IN PATIENTS WITH ACTIVE ULCERATIVE-COLITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Gastroenterology, 106(4), 1994, pp. 10000698-10000698
Authors:
DEPRE M
FRIEDMAN B
VANHECKEN A
DELEPELEIRE I
TANAKA W
DALLOB A
SHINGO S
PORRAS A
LIN C
DESCHEPPER PJ
Citation: M. Depre et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ORAL DOSES OF MK-0591, A 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 22-30
Authors:
LASKIN OL
PATTERSON PM
SHINGO S
LASSETER KC
SHAMBLEN EC
Citation: Ol. Laskin et al., PHARMACODYNAMICS AND DOSE-RESPONSE RELATIONSHIP OF FAMOTIDINE - A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL, Journal of clinical pharmacology, 33(7), 1993, pp. 636-639
Authors:
MCCREA JB
FRUNCILLO RJ
HOLLAND SD
CONROY JA
SHINGO S
SPECTOR R
BJORNSSON TD
Citation: Jb. Mccrea et al., LOVASTATIN DOES NOT AFFECT ORAL GLUCOSE-TOLERANCE IN HYPERCHOLESTEROLEMIC PATIENTS, Journal of clinical pharmacology, 33(6), 1993, pp. 581-585
Authors:
MURPHY MG
SYTNIK B
KOVACS TOG
MERTZ H
EWANIK D
SHINGO S
LIN JH
GERTZ BJ
WALSH JH
Citation: Mg. Murphy et al., THE GASTRIN-RECEPTOR ANTAGONIST L-365,260 INHIBITS STIMULATED ACID-SECRETION IN HUMANS, Clinical pharmacology and therapeutics, 54(5), 1993, pp. 533-539
Authors:
IMPENS N
REISS TF
TEAHAN JA
DESMET M
ROSSING TH
SHINGO S
JI Z
SCHANDEVYL W
VERBESSELT R
DUPONT AG
Citation: N. Impens et al., ACUTE BRONCHODILATION WITH AN INTRAVENOUSLY ADMINISTERED LEUKOTRIENE-D(4) ANTAGONIST, MK-679, The American review of respiratory disease, 147(6), 1993, pp. 1442-1446